study is here is anyone is interested
https://www.ncbi.nlm.nih.gov/pmc/articles/pmc6628006/there are a lot of azole antifungals that score highly on the list
Results
Activity of top 41 active hits that had good activity against stationary phase B. henselae
Drugs (50 μM) Residual Viable Cell Percentage
Primary Screen b Confirmation Microscopy c
Drug free control 60% 81%
Gentamicin 2% 32%
Azithromycin 17% 42%
Streptomycin 9% 39%
Tetracycline 12% 50%
Rifampin 2% 59%
Doxycycline 11% 60%
Penicillin 13% 60%
Erythromycin 14% 66%
Chloramphenicol 13% 70%
Cefuroxime 21% 73%
Ciprofloxacin 30% 74%
Pyrvinium pamoate 0% d ND e
Amifostine 27% 10%
Daptomycin 7% 21%
Lopinavir/ritonavir 9% 21%
Sulconazole 3% 22%
Econazole 8% 22%
Oxiconazole 3% 24%
Butoconazole 11% 25%
Methylene blue 16% 25%
Clotrimazole 7% 27%
Dibekacin * 9% 28%
Abamectin * 2% 30%
Colistin 4% 30%
Bifonazole 4% 31%
Amikacin 12% 32%
Nitroxoline 6% 33%
Miconazole 8% 35%
Chlorosalicylanilide * 17% 38%
Berberine 8% 39%
Meclocycline * 11% 40%
Nebramycin * 2% 41%
Kanamycin 9% 44%
Dichlorophen * 14% 45%
Verteporfin 0% d 45%
Pentamidine 15% 46%
Cloxyquin * 7% 48%
Aprepitant 0% d 49%
Puromycin * 6% 49%
Amaranth * 3% 50%
Lomerizine * 8% 51%
Carbomycin * 16% 52%
Spiramycin * 14% 53%
Thiethylperazine 4% 55%
Clinafloxacin 11% 56%
Clofoctol 12% 58%
Meclizine 11% 60%
Pazufloxacin * 12% 62%
Nitrofurantoin 16% 63%
Diclazuril * 15% 64%
Olsalazine 18% 64%
Nifuroxazide * 7% 65%